Study types
- other 5
- case-report 1
Condition tags
- endometriosis 6
- infertility 2
- dysmenorrhea 1
- endometrioma 1
Top journals
Frequent coauthors
- Shiori Takeuchi 6
- Kuwatsuru Y 3
- Kanazawa K 3
- Yoshizawa H 3
- Kobayashi M 3
- Murakami K 2
- Minoura H 2
- Mari Kitade 2
- Keisuke Murakami 2
- H Minoura 2
OBJECTIVE: To retrospectively evaluate the clinical features, perioperative findings, and long-term outcomes of patients who underwent bowel resection for intestinal endometriosis, and to clarify diagnostic and therapeutic challenges with t…
AIM: To evaluate the incidence of tubo-ovarian abscess (TOA) in patients with ovarian endometrioma (OE) undergoing infertility treatment and to describe treatment approaches and clinical outcomes, including transvaginal ultrasound-guided dr…
BackgroundClassifying uterine fibroid using the International Federation of Gynecology and Obstetrics (FIGO) classification system assists treatment decision-making and planning. This study aimed to study whether different fibroid locations…
Ureterocolic fistula is a rare phenomenon and cases secondary to diverticulitis are even rarer. We present a case of ureterocolic fistula secondary to diverticulitis of the sigmoid colon following laparoscopic salpingo-oophorectomy due to e…
PURPOSE: The objective was to determine the optimal insemination technique in patients undergoing in vitro fertilization (IVF) after failed direct intraperitoneal insemination (DIPI) and the outcome of intracytoplasmic sperm injection (ICSI…
Endometriosis occasionally involves the urinary tract, and a ureteral obstruction from this order constitutes a rare variant with serious consequences. Intrinsic ureteric involvement by endometriosis is an exceedingly rare event. This case …
Human fibroblast interferon (IFN-beta) was given 13 cases of advanced gynecological cancers. Eight patients, who were clinically evaluable, were reported as follows; Patients consisted of ovarian adenocarcinoma (5), cervical adenocarcinoma …
Cisplatin (cis-diamminedichloroplatinum) was administered to 20 patients with histologically proven ovarian cancer. Ten of 20 patients were evaluable. They consisted of 1 patient by single use and 9 by combined use. The dose of cisplatin in…